Central integration of peripheral signals in the regulation of food intake and energy balance: Role of leptin and insulin

Handbook of Obesity: Etiology and Pathophysiology, Second Edition

Volumn , Issue , 2003, Pages 461-479

  Campfield, L Arthur ^a   Smith, Françoise J ^a   Jeanrenaud, Bernard ^b  

^a Department of Environmental and Radiological Health Sciences   (United States)

^b UNIVERSITY OF GENEVA   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 35348951763     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (126)

1. Campfield LA, Smith FJ. The pathogenesis of obesity. In: Bray GA, ed. Bailliere's Clinical Endocrinology and Metabolism. London: Bailliere Tindal, 1999:13–30.
2. Campfield LA, Smith FJ, Burn P. Strategies and potential molecular targets for obesity treatment. Science 1998; 280:1383–1387.
3. Campfield LA. Multiple facets of OB protein (leptin) physiology: integration of central and peripheral mechanisms in the regulation of energy balance. In: Ailhaud G, Guy-Grand B, eds. Progress in Obesity Research: 8. London: John Libbey & Company, 1999:327–335.
4. Considine RV, Sinha MK, Heiman ML, Kriauciunas A, Stephens TW, Nyce MR, Ohannesian JP, Marco CC, McKee LJ, Baur TL, Caro JF. Serum immunoreactive-leptin concentrations in normal-weight and obese humans. N Engl J Med 1996; 334:192–295.
5. Maffei M, Halaas J, Ravussin E, Pratley RE, Lee GH, Zhang Y, Fei H, Kim S, Lallone R, Ranganathan S, Kern PA, and Friedman JM. Leptin levels in human and rodent: measurement of plasma leptin and ob mRNA in obese and weight-reduced subjects. Nat Med 1995; 1:1155–1161.
6. Kennedy GC. The role of depot fat in the hypothalamic control of food intake in the rat. Proc R Soc Lond Ser B 1953; 140:578–592.
7. Campfield LA, Smith FJ, Burn P. The OB protein (leptin) pathway—a link between adipose tissue mass and central neural networks. Horm Metab Res 1996; 28:619–632.
8. Campfield LA, Smith FJ, Burn P. OB protein: a hormonal controller of central neural networks mediating behavioral, metabolic and neuroendocrine responses. Endocrinol Metab 1997; 4:81–102.
9. Kaiyala KJ, Woods SC, Schwartz MW. New model for the regulation of energy balance and adiposity by the central nervous system. Am J Clin Nutr 1995; 62:1123s–1134s.
10. Schwartz MW, Woods SC, Porte D Jr, Seeley RJ, Baskin DG. Central nervous system control of food intake. Nature 2000; 404:661–671.
11. De Matteis R, Dashtipour K, Ognibene A, Cinti S. Localization of leptin receptor splice variants in mouse peripheral tissues by immunohistochemistry. Proc Nutr Soc 1998; 57:441–448.
12. Zhang Y, Proenca R, Maffei M, Barone M, Leopold L, Friedman JM. Positional cloning of the mouse obese gene and its human homologue. Nature 1994; 372:425–431.
13. Leibel RL, Rosenbaum M, Hirsch J. Changes in energy expenditure resulting from altered body weight. N Engl J Med 1995; 232:621–628.
14. Campfield LA, Smith FJ. Overview: neurobiology of OB protein (leptin). Proc Nutr Soc 1998; 57:429–440.
15. Le Magnen J. The metabolic basis of the dual periodicity of feeding in rats. Behav Brain Sci 1980; 4:561–607.
16. Le Magnen J. Hunger. London: Cambridge University Press, 1985.
17. Le Magnen J. Neurobiology of Feeding and Nutrition. San Diego: Academic Press, 1992.
18. Campfield LA, Smith FJ. Systemic factors in the control of food intake: evidence for patterns as signals. In: Stricker EM, ed. Handbook of Behavioral Neurobiology, Vol 10. Neurobiology of Food and Fluid Intake. New York: Plenum Press, 1990:183–206.
19. Campfield LA. Metabolic and hormonal controls of food-intake: highlights of the last 25 year—1972-1997. Appetite 1997; 29:135–152.
20. Woods SC, Seeley RJ, Porte D Jr, Schwartz MW. Signals that regulate food intake and energy homeostasis. Science 1998; 280:1378–1383.
21. Bray GA, Campfeld LA. Metabolic factors in the control of energy stores. Metabolism 1975; 24:99–117.
22. Bogardus C, Lillioja S, Ravussin E, Abbott W, Zawadzki JK, Young A. Familial dependence of the resting metabolic rate. N Engl J Med 1986; 315:96–100.
23. Keesey RE. Physiological regulation of body weight and the issue of obesity. Med Clin North Am 1989; 73:15–27.
24. Hill JO, Douglas HJ, Peters JC. Physical activity, fitness, and moderate obesity. In: Bouchard C, Shepard RJ, Stephens T, eds. Physical Activity Fitness, and Health: International Proceedings and Consensus Statement. Champaign (Illinois): Human Kinetics Publisher Inc., 1994.
25. World Health Organization. Obesity: Preventing and Managing the Global Epidemic. Geneva: World Health Organization, 1998.
26. Astrup A. Obesity as an adaptation to a high-fat diet: evidence from a cross-sectional study. Am J Clin Nutr 1994; 59:350–355.
27. Ingalls AM, Dickie MM, Snell GD. Obese, a new mutaion in the house mouse. J Hered 1950; 41:317–325.
28. Coleman DI. Obese and diabetes: two mutant genes causing diabetes-obesity syndromes in mice. Diabet- ologia 1978; 14:141–1148.
29. Coleman DL. Effects of parabiosis of obese with diabetes and normal mice. Diabetologia 1973; 9:294–298.
30. Coleman DL. Inherited obesity-diabetes syndromes in the mouse. Prog Clin Biol Res, 1981; 45:145–158.
31. Coleman DL, Hummel KP. The influence of genetic background on the expression of the obese (ob) gene in the mouse. Diabetologia 1973; 9:287–293.
32. Herberg L, Coleman DL. Laboratory animals exhibiting obesity and diabetes syndromes. Metabolism 1977; 26:59–99.
33. Sinha MK, Ohannesian JP, Heiman ML, Kriaucinunas A. Nocturnal rise in leptin in lean, obese, and noninsulin-dependent diabetes mellitus subjects. J Clin Invest 1996; 97:1344–1347.
34. Van Aggel-Leijssen DP, Van Baak MA, Tenenbaum R, Campfield LA, Saris WHM. Regulation of average 4h human plasma leptin level; the influence of exercise and physiological changes in energy balance. Int J Obes Relat Metab Disord 1999; 23:151–158.
35. Porte D Jr. Banting Lecture 1990. Beta-cells in type II diabetes mellitus. Diabetes 1991; 40:166–80.
36. Woods SC, Nolan LJ. The insulin story: a 25-year perspective. Appetite 1997; 28:281–282.
37. Schwartz MW, Figlewicz DP, Baskin DG, Woods SC, Porte D Jr. Insulin and the central regulation of energy balance: Update 1994. Endocr Rev 1994; 2:109–113.
38. Banks WA, Kastin AJ, Huang W, Jaspan JB, Maness LM. Leptin enters the brain by a saturable system independent of insulin. Peptides 1996; 17:305–311.
39. Golden PL, Maccagnan TJ, Pardridge WM. Human blood-brain barrier leptin receptor. Binding and endocytosis in isolated human brain microvessels. J Clin Invest 1997; 99:14–18.
40. Campfield LA, Smith FJ, Guisez Y, Devos R, Burn P. Recombinant mouse OB protein: Evidence for a peripheral signal linking adiposity and central neural networks. Science 1995; 269:546–549.
41. Stephens TW, Basinski M, Bristow PK, Bue-Valleskey JM, Burgett SG, Craft L, Hale J, Hoffmann J, Hsiung HM, Kriauciunas A, MacKeller W, Rosteck PR Jr, Schoner B, Smith D, Tinsley FC, Zhang X-Y, Heiman M. The role of neuropeptide Y in the antiobesity action of the obese gene product. Nature 1995; 377:530–532.
42. Seeley RJ, Van Dijk G, Campfield LA, Smith FJ, Burn P, Nelligan JA, Bell MS, Baskin DG, Woods SC, Schwartz MW. Intraventricular leptin reduces food intake and body weight of lean rats but not obese Zucker rats. Horm Metab Res 1996; 28:664–668.
43. Pelleymounter M, Cullen M, Baker M, Hecht R, Winters D, Bone T, Collins F. Effects of the obese gene product on body weight regulation in ob/ob mice. Science 1995; 269:540–543.
44. Rentsch J, Levens N, Chiesi M. Recombinant ob-gene product reduces food intake in fasted mice. Biochem Biophys Res Commun 1995; 214:131–136.
45. Halaas JL, Gajiwala KS, Maffei M, Cohen SL, Chait BT, Rabinowitz D, Lallone RL, Burley SK, Friedman JM. Weight-reducing effects of the plasma protein encoded by the obese gene. Science 1995; 269:543–546.
46. Schwartz MW, Baskin DG, Bukowski TR, Kuijper JL, Foster D, Lasser G, Prunkard DE, Porte D Jr, Woods SC, Seeley RJ, Weigle DS. Specificity of leptin action on elevated blood glucose levels and hypothalamic neuropeptide Y gene expression in ob/ob mice. Diabetes 1996; 45:531–535.
47. Shimabukuro M, Koyama K, Chen G. Direct effects of leptin through triglyceride depletion of tissues. Proc Natl Acad Sci USA 1997; 94:4637–4641.
48. Cusin I, Rohner-Jeanrenaud F, Stricker-Krongrad A, Jeanrenaud B. The weight-reducing effect of an intracerebroventicular bolus injection of leptin in genetically obese fa/fa rats. Reduced sensitivity compared with lean animals. Diabetes 1996; 1446–1450.
49. Rohner-Jeanrenaud F, Cusin I, Sainsbury A, Zakr- zewska K, Jeanrenaud B. Neuropeptide Y and leptin in lean and genetically obese fa/fa rats. Horm Metab Res 1996; 28:642–648.
50. Lin L, Truett GE, Levans N, York DA. Central, but not peripheral administration of leptin reduced the food intake and body weight in Zucker fatty and lean rats. Obes Res 1996; 4:1S.
51. Wildman HF, Chau SCJ, Leibel RL, Smith GP. Effects of leptin and cholecystokinin in rats with a null mutation of the leptin receptor leprfak. Am J Physiol 2000; 278:R1518–R1523.
52. Thiele TE, Van Dijk G, Campfield LA, Smith FJ, Burn P, Woods SC, Bernstein IL, Seeley RJ. Central infusion of GLP-1, but not leptin, produces conditioned taste aversion in rats. Am J Physiol 1997; 272:R726–R730.
53. Farooqi IS, Jebb SA, Langmack G, Lawrence E, Cheetham CH, Prentice AM, Hughes IA, McCamish MA, O'Rahilly S. Effects of recombinant leptin therapy in a child with congenital leptin deficiency. N Engl J Med 1999; 341:879–884.
54. Heymsfield SB, Greenberg AS, Fujioka K, Dixon RM, Kushner R, Hunt T, Lubina JA, Patane J, Self B, Hunt P, McCamish M. Recombinant leptin for weight loss in obese and lean adults: a randomized, controlled, dose-escalation trial. JAMA 1999; 282:1568–75.
55. Hukshorn CJ, Saris WH, Westerterp-Plantenga MS, Farid AR, Campfield LA. Weekly subcutaneous pegylated recombinant native human leptin (PEG- OB) administration in obese men. J Clin Endocrinol Metab 2000; 85:4003–4009.
56. Westerterp-Plantenga MS, Saris WH, Hukshorn CJ, Campfield LA. Effects of weekly administration of pegylated recombinant human OB protein on appetite profile and energy metabolism in obese men. Am J Clin Nutri 2001; 74:426–434.
57. Devos R, Richards JG, Campfield LA, Tartaglia LA, Guisez Y, Van der Heyden J, Travernier J, Plaetinck G, Burn P. OB protein binds specifically to the choriod plexus of mice and rats. Proc Natl Acad Sci USA 1996; 93:5668–5673.
58. Lynn RB, Cao GY, Considine RV, Hyde TM, Caro JF. Autoradiographic localization of leptin binding in the choroid plexus of ob/ob and db/db mice. Biochem Biophys Res Commun 1996; 219:884–889.
59. Corp ES, Conze DB, Smith F, Campfield LA. Regional localization of specific [125I]leptin binding sites in rat forebrain. Brain Res 1998; 789:40–47.
60. Tartaglia LA, Dembski M, Weng X, Deng N, Culpepper J, Devos R, Richards JG, Campfield LA, Clark FT, Deeds J, Muir C, Sanker S, Moriarty A, Moore KJ, Smutko JS, Mays GG, Woolf EA, Monroe Tepper RI. Identification and expression cloning of a leptin receptor (OB-R). Cell 1995; 83: 1263–1271.
61. Mercer JG, Hoggard N, Williams LM, Lawrence CB, Hannah LT, Trayhurn P. Localization of leptin receptor mRNA and the long form splice variant (OB-Rb) in mouse hypothalamus and adjacent brain regions by in situ hybridization. FEBS Lett 1996; 387:113–116.
62. Ghilardi N, Ziegler S, Wiestner A, Stoffel R, Heim MH, Skoda RC. Defective STAT signaling by the leptin receptor in diabetic mice. Proc Natl Acad Sci USA 1996; 93:6231–6235.
63. Schwartz MW, Seeley RJ, Campfield LA, Burn P, Baskin DG. Identification of targets of leptin action in rat hypothalamus. J Clin Invest 1996; 98:1101–1106.
64. Elmquist JK, Bjorbaek C, Ahima RS, Flier JS, Saper CB. Distributions of leptin receptor mRNA isoforms in the rat brain. J Comp Neurol 1998; 395:535–547.
65. Lee G, Proenca R, Montez JM, Carrol KM, Darvish- zadeh JG, Lee JI, Friedman JM. Abnormal splicing of the leptin receptor in diabetic mice. Nature 1996; 379:632–635.
66. Chua SC, Chung WK, Wu-Peng XS, Zhang Y, Liu S-M, Tartaglia L, Leibel RL. Phenotypes of mouse diabetes and rat fatty due to mutations in the OB (leptin) receptor. Science 1996; 271:994–996.
67. Chen H, Charlat O, Tartaglia LA, Woolf EA, Weng X, Ellis SJ, Lakey ND, Culpepper J, Moore KJ, Breitbart RF, Duyk GM, Tepper RI, Morgenstern JP. Evidence that the diabetes gene encodes the leptin receptor: identification of a mutation in the leptin receptor gene in db/db mice. Cell 1996; 84:491–495.
68. Takaya K, Ogawa Y, Hiroaka J, Hosoda K, Yamori Y, Nakao K, Koletsky RJ. Nonsense mutation of leptin receptor in the obese spontaneously hypertensive Koletsky rat. Nat Gene 1996; 14:130–131.
69. Wu-Peng XS, Chau SCJ, Okada N, Liu SM, Nicolson M, Leibel RL. Phenotype of the obese Koletsky (f) rat due to tyr763stop mutation in the extracellular domain of the leptin receptor (LEPR): evidence for deficient plasmato-csf transport of leptin in both the Zucker and Koletsky obese rat. Diabetes 1997; 46: 513–518.
70. Tartaglia LA. The leptin receptor. J Biol Chem 1997; 272:6093–6096.
71. White DW, Tartaglia LA. Leptin and OB-R: body weight regulation by a cytokine receptor. Cytokine Growth Factor Rev 1996; 7:303–309.
72. Campfield LA, Smith FJ, Yu J, Renzetti M, Simko B, Baralt M, Mackie G, Tenenbaum R, Smith W. Dietary obesity induces decreased central sensitivity to exogenous OB protein (leptin) which is reversed by weight loss. Soc Neurosci Abstr 1997; 23:815.
73. Schwartz MW, Marks J, Sipols AJ, Baskin DB, Woods SC, Kahn SE, Prote JD. Central insulin administration reduces neuropeptide Y mRNA expression in the arcuate nucleus of food-deprived lean (fa/fa) but not obese (fa/fa) Zucker rats. Endocrinology 1991; 128:2645–2647.
74. Elmquist JK. Hypothalamic pathways underlying the endocrine, autonomic, and behavioral effects of leptin. Int J Obes Relat Metab Disord 2001; 25:S78- S82.
75. Elias CF, Lee CE, Kelly JF, Ahima RS, Kuhar M, Saper CB, Elmquist JK. Characterization of CART neurons in the rat and human hypothalamus. J Comp Neurol 2001; 432:1–19.
76. Ahima RS, Saper CB, Flier JS, Elmquist JK. Leptin regulation of neuroendocrine systems. Front Neuroendocrinol 2000; 21:263–307.
77. Elias CF, Kelly JF, Lee CE, Ahima RS, Drucker DJ, Saper CB, Elmquist JK. Chemical characterization of leptin-activated neurons in the rat brain. J Comp Neurol 2000; 423:261–281.
78. Elmquist JK. Anatomic basis of leptin action in the hypothalamus. Front Horm Res 2000; 26:21–41.
79. Ahima RS, Kelly J, Elmquist JK, Flier JS. Distinct physiologic and neuronal responses to decreased leptin and mild hyperleptinemia. Endocrinology 1999; 140:4923–4931.
80. Elias CF, Aschkenasi C, Lee C, Kelly J, Ahima RS, Bjorbaek C, Flier JS, Saper CB, Elmquist JK. Leptin differentially regulates NPY and POMC neurons projecting to the lateral hypothalamic area. Neuron 1999; 23:775–786.
81. Elmquist JK, Maratos-Flier E, Saper CB, Flier JS. Unraveling the central nervous system pathways underlying responses to leptin. Nat Neurosci 1998; 1:445–450.
82. Huang Q, Rivest R, Richard D. Effects of leptin on corticotropin-releasing factor (CRF) synthesis and CRF neuron activation in the paraventricular hypothalamic nucleus of obese (ob/ob) mice. Endocrinology 1998; 139:1524–1532.
83. Spanswick D, Smith MA, Groppi VE, Logan SD, Ashford MLJ. Leptin inhibits hypothalamic neurons by activation of ATP-senstive potassium channels. Nature 1997; 390:521–525.
84. Yokosuka M, Xu B, Pu S, Karla SP. The magnocel- lular part of the paraventricular hypothalamic nucleus (PVN): a selective site for inhibition of NPY-induced food intake by leptin. Soc Neurosci Abstr 1997; 23: 852.
85. Van Dijk G, Theile TE, Donahey JCK, Campfield LA, Smith FJ, Burn P, Bernstein IL, Woods SC, Selley RJ. Central infusion of leptin and GLP-1(7-36) amide defferentially stimulate c-FLI in the rat brain. Am J Physiol 1996; 271:R1096–Rl100.
86. Collins S, Kuhn CM, Petro AE, Swick AG, Chrunyk BA, Surwit RS. Role of leptin in fat regulation. Nature 1996; 380:677.
87. Hakansson M-L, Brown H, Ghilardi N, Skoda RC, Meister B. Leptin receptor immunoreactivity in chemically defined target neurons of the hypothalamus. J Nueorosci 1998; 18:559–572.
88. Chen SC, Kochan JP, Campfield LA, Burn P, Smeyne RJ. Splice variants of the OB receptor gene are differentially expressed in brain and peripheral tissues of mice. J Recept Signal Transduct Res 1999; 19:245–266.
89. Haynes WG, Morgan DA, Walsh SA, Marks AL, Sivitz WI. Receptor-mediated regional sympathetic nerve by leptin. J Clin Invest 1997; 100:270–278.
90. Elias CF, Lee C, Kelly J, Aschkenasi C, Ahima RS, Couceyro PR, Kuhar MJ, Saper CB, Elmquist JK. Leptin activates hypothalamic CART neurons projecting to the spinal cord. Neuron 1998; 21:1375–1385.
91. Fan W, Boston BA, Kesterson RA, Hruby VJ, Cone RD. Melanocortinergic inhibition of feeding behavior and disruption with an agoutimimetic. Nature 1997; 385:165–168.
92. Arvaniti K, Huang Q, Richard D. Effects of leptin and corticosterone on the expression of corticotropin- releasing hormone, agouti-related protein, and proopiomelanocortin in the brain of ob/ob mouse. Neuroendocrinology 2001; 73:227–236.
93. Rohner-Jeanrenaud F, Jeanrenaud B. Obesity, leptin, and the brain. N Engl J Med 1996; 334:324–325.
94. Ezzell C. Fat times for obesity research: Tons of new information, but how does it all fit together. J NIH Res 1995; 7:39–45.
95. Stanley BG, Kyrkouli SE, Lampert S, Leibowitz SF. Neuropeptide Y chronically injected into the hypothalamus: a powerful neurochemical inducer of hyperphagia and obesity. Peptides 1986; 7:189–192.
96. Stricker-Krongrad A, Chiesi M, Cumin F, Spanka C, Whitesbread S, Rentsch J, Lollman B, Hofbauer KG, Levens N. Interactions between leptin and neuropeptide Y in the control of food intake in the rat. Obes Res 1996; 4(1):37s.
97. Smith FJ, Campfield LA, Moschera JA, Bailon P, Burn P. Feeding inhibition by neuropeptide Y. Nature 1996; 382:307.
98. Erickson JC, Clegg KE, Palmiter RD. Sensitivity to leptin and susceptibility to seizures of mice lacking neuropeptide Y. Nature 1996; 381:415–418.
99. Erickson JC, Hollopetter G, Palmiter RD. Attenuation of the obesity syndrome of ob/ob mice by the loss of neuropeptide Y. Science 1996; 274:1704–1707.
100. Jeanrenaud B, Rohner-Jeanrenaud F. Effects of neuropeptides and leptin on nutrient partitioning: dysregulations in obesity. Annu Rev Med 2001; 52:339–351.
101. Jeanrenaud B, Rohner-Jeanrenaud F. CNS-periphery relationships and body weight homeostasis: influence of the glucocorticoid status. Int J Obes Relat Metab Disord 2000; 24:S74–S76.
102. Zakrzewska KE, Cusin I, Sainsbury A, Rohner-Jeanrenaud F, Jeanrenaud B. Glucocorticoids as counterregulatory hormones of leptin: toward an understanding of leptin resistance. Diabetes 1997; 46:717–719.
103. Zakrzewska KE, Sainsbury A, Cusin I, Rouru J, Jeanrenaud B, Rohner-Jeanrenaud F. Selective dependence of intracerebroventricular neuropeptide Y-elicited effects on central glucocorticoids. Endocrinology 1999; 140:3183–3187.
104. Sainsbury A, Cusin I, Rohner-Jeanrenaud F, Jeanre- naud B. Adrenalectomy prevents the obesity syndrome produced by chronic central neuropeptide Y infusion innormal rats. Diabetes 1997; 46:209–214.
105. Zarjevski N, Cusin I, Vettor R, Rohner-Jeanrenaud F, Jeanrenaud B. Chronic intercerebroventricular neuropeptide Y administraton to normal rats mimics hormonal and metabolic changes to obesity. Endocrinology 1993; 133:1753–1758.
106. Zakrzewska KE, Cusin I, Stricker-Krongrad A, Boss O, Ricquier D, Jeanrenaud B, Rohner-Jeanrenaud F. Induction of obesity and hyperleptinemia by central glucocorticoid infusion in the rat. Diabetes 1999; 48:365–370.
107. Bray GA, York DA. Hypothalamic and genetic obesity in experimental animals: an automonic and endocrine hypothesis. Physiol Rev 1979; 59:719–809.
108. Ahima RS, Prabakaren D, Mantzoros C, Ou D, Lowell B, Maratzoros-Flier E, Flier J. Role of leptin in the neuroendocrine responses to fasting. Nature 1996; 382:250–252.
109. Huszar D, Lynch CA, Fairchild-Huntress V, Dunmore JH, Fang Q, Berkemeier LR, Gu W, Kesterson RA, Boston BA, Cone RD, Smith FJ, Campfield LA, Burn P, Lee F. Targeted disruption of the melano-cortin-4 receptor results in obesity in mice. Cell 1997; 88:131–141.
110. Ludwig DS, Tritos NA, Mastaitis JW, Kulkarni R, Kokkotou E, Elmquist J, Lowell B, Flier JS, Maratos-Flier E. Melanin-concentrating hormone overexpression in transgenic mice leads to obesity and insulin resistance. J Clin Invest 2001; 107:379–386.
111. Shimada M, Tritos NA, Lowell BB, Flier JS, Maratos-Flier E. Mice lacking melanin-concentrating hormone are hypophagic and lean. Nature 1998; 396:670–674.
112. Tritos NA, Maratos-Flier E. Two important systems in energy homeostasis: melanocortins and melanin-concentrating hormone. Neuropeptides 1999; 33:339–334.
113. Schwartz MW, Seeley RJ, Woods SC, Weigle DS, Campfield LA, Burn P, Baskin DG. Leptin increases hypothalamic pro-opiomelanocortin mRNA expression in the rostral arcuate nucleus. Diabetes 1997; 46:2119–2123.
114. Boston BA, Blaydon KM, Varerin J, Cone RD. Independent and additive effects of central POMC and leptin pathways on murine obesity. Science 1997; 278:1641–1644.
115. Chen AS, Metzger JM, Trumbauer ME, Guan XM, Yu H, Frazier EG, Marsh DJ, Forrest MJ, Gopal-Truter S, Fisher J, Camacho RE, Strack AM, Mellin TN, MacIntyre DE, Chen HY, Van der Ploeg LH. Role of the melanocortin-4 receptor in metabolic rate and food intake in mice. Transgenic Res 2000; 9:145–154.
116. Butler AA, Kesterson RA, Khong K, Cullen MJ, Pelleymounter MA, Dekoning J, Baetscher M, Cone RD. A unique metabolic syndrome causes obesity in the melanocortin-3 receptor-deficient mouse. Endocrinology 2000; 141:3518–3521.
117. Butler AA, Cone RD. Knockout models resulting in the development of obesity. Trends Genet 2001; 17:S50–S54.
118. Miller KA, Gunn TM, Carrasquillo MM, Lamoreux ML, Galbraith DB, Barsh GS. Genetic studies of the mouse mutations mahogany and mahoganoid. Genetics 1997; 146:1407–1415.
119. Gibbs J, Young RC, Smith GP. Cholecystokinin decreases food intake in rats. J Comp Physiol Pyschol 1973; 84:488–495.
120. Smith GP, Gibbs J. Satiating effect of cholecystokinin. Ann NY Acad Sci 1994; 713:236–241.
121. Moran TH, Robinson PH, Goldrich MS, McHugh PR. Two brain cholecystokinin receptor: implications for behavioral actions. Brain Res 1986; 362:175–179.
122. Riedy CA, Chavez M, Figlewicz DP, Woods SC. Central insulin enhances sensitivity to cholecystokinin. Phyiol Behav 1995; 58:755–760.
123. Chehab F, Lim M, Lu R. Correction of the sterility defect in homozygous obese female by treatment with human recombinant leptin. Nat Genet 1996; 12:318–320.
124. Clement K, Valisse C, Lahlou N, Cabrol S, Peeloux V, Cassuto D, Gourmelen M, Dina C, Chambaz J, Lacourte M, Basdevant A, Bougneres P, Lebouc Y, Froguel P, Guy-Grand B. A mutation in the human leptin receptor gene causes obesity and pituitary dysfunction. Nature 1998; 392:398–401.
125. Strobel A, Issad T, Camoin L, Ozata M, Strosberg D. A leptin missense mutation associated with hypogonadism and morbid obesity. Nat Gene 1998; 18:213–215.
126. Thomas PR, ed. Weighing the Options: Criteria for Evaluating Weight Management Programs. Washington: National Academy Press, 1995.